STEPHEN DOUGLAS HENRY M.D. NPI 1811925183

NPI Details

Stephen Douglas Henry, M.D. is a geriatric medicine internal medicine in Pasadena, CA with 50 years of experience. The provider is an internist who has special knowledge of the aging process and special skills in the diagnostic, therapeutic, preventive and rehabilitative aspects of illness in the elderly. This specialist cares for geriatric patients in the patient's home, the office, long-term care settings such as nursing homes and the hospital. Stephen Douglas Henry, M.D. NPI is 1811925183. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: INDIANA UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1976

The provider's business location address is:

2319 E WASHINGTON BLVD
SUITE 2
PASADENA, CA
ZIP 91104-945
Phone: (626) 797-8800
Fax: (626) 797-8575

The NPI 1811925183 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 05D0556018 - physician office with a certificate type of Certificate for Provider-Performed Microscopy Procedures (PPMP).

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone enanthate, 1 mg (HCPCS:J3121)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc (HCPCS:U0002)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• X-ray of chest, 1 view (HCPCS:71045)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
• Injection, amikacin sulfate, 100 mg (HCPCS:J0278)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Removal of impacted ear wax (HCPCS:69210)
• Injection, cefazolin sodium, 500 mg (HCPCS:J0690)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, thiamine hcl, 100 mg (HCPCS:J3411)
• Injection, pyridoxine hcl, 100 mg (HCPCS:J3415)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
• Injection, bebtelovimab, 175 mg (HCPCS:Q0222)
• Dressing change under anesthesia (HCPCS:15852)
• Insertion of needle into vein (3 years or older) (HCPCS:36410)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• X-ray of chest, 2 views (HCPCS:71046)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 6/28/2006 and was last updated on 5/18/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.